Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. (RNAC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RNAC · as of Jun 9, 2026
Key Statistics
Explore Cartesian Therapeutics, Inc. Data
rnac stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 80.0%
The RNAC analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $20.50, representing +249.83% upside from the current price of $5.86.
Competitors & Peers
rnac competitorsRNAC
AARD
AVTX
EPRX
FENC
GNFTStock Performance
Full HistoryAbout Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to the advancement and discovery of nanoparticle-based immunomodulatory drugs. These innovative therapeutics are…
what is cartesian therapeutics, inc. · rnac stock overview · cartesian therapeutics, inc. company profile · who is cartesian therapeutics, inc. ceo · rnac NASDAQ · cartesian therapeutics, inc. headquarters · cartesian therapeutics, inc. business segments
About Stock Overview & Key Data
Cartesian Therapeutics, Inc. (RNAC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 22, 2016. As of the latest trading session, RNAC stock price is $5.86, with a market capitalization of $172.2M. The stock has returned -45.99% over the past 12 months and -18.72% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Cartesian Therapeutics, Inc. stock is Buy, with an average 12-month price target of $20.50. In fiscal year 2025, Cartesian Therapeutics, Inc. reported revenue of $2.8M and net income of -$130.3M. For detailed data — including Cartesian Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cartesian Therapeutics, Inc. (RNAC) stock price is $5.86. The stock is traded on NASDAQ under the ticker symbol RNAC. The 52-week range is $5.60 – $15.57.